Literature DB >> 2305053

Thoracic manifestations of Wegener granulomatosis: diagnosis and course.

D R Aberle1, G Gamsu, D Lynch.   

Abstract

A combination of cytotoxic and corticosteroid therapy has dramatically improved the long-term survival of patients with Wegener granulomatosis. With extended survival, patients now experience diverse cardiopulmonary abnormalities that represent primary or secondary manifestations of the disease or that result from diagnosis and treatment. To evaluate these abnormalities, the authors reviewed the medical histories and chest radiologic findings of 19 patients with the histologic diagnosis of Wegener granulomatosis. In these patients thoracic images demonstrated parenchymal nodules or consolidations with cavitation, diffuse interstitial disease, mediastinal or hilar adenopathy, and isolated stenoses of the larynx or tracheobronchial tree. Intrathoracic relapse occurred in 18 cases; in one-third of these patients, findings at relapse differed from those at initial presentation. Complications from diagnosis or therapy occurred in nine patients. Pulmonary infection was the most frequent complication causing morbidity and was often clinically indistinguishable from the primary disease; it complicated relapse in five patients. The successful radiologic follow-up of patients with Wegener granulomatosis requires a consideration of the varied thoracic manifestations of both the primary disease and the complications of its treatment.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2305053     DOI: 10.1148/radiology.174.3.2305053

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  12 in total

Review 1.  Imaging of the pulmonary manifestations of systemic disease.

Authors:  A G Rockall; D Rickards; P J Shaw
Journal:  Postgrad Med J       Date:  2001-10       Impact factor: 2.401

Review 2.  Cavitary pulmonary disease.

Authors:  L Beth Gadkowski; Jason E Stout
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

3.  A patient with Down's syndrome and anti-neutrophilic cytoplasmic antibody-positive vasculitis.

Authors:  M Schwab; M Böswald; K Ludwig; C Wittekind; R Waldherr; H Ruder
Journal:  Pediatr Nephrol       Date:  1996-04       Impact factor: 3.714

Review 4.  Pulmonary vasculitis: classification, clinical features, and management.

Authors:  A Ciaccia; M Ferrari; F M Facchini; G Caramori; L Fabbri
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

5.  New perspectives in Wegener's granulomatosis.

Authors:  R B Dreisin
Journal:  Thorax       Date:  1993-02       Impact factor: 9.139

Review 6.  Pulmonary vasculitis: diagnosis and endovascular therapy.

Authors:  Kiran Batra; Murthy Chamarthy; Rodrigo Caruso Chate; Kirk Jordan; Fernando Uliana Kay
Journal:  Cardiovasc Diagn Ther       Date:  2018-06

7.  Chest CT findings in pediatric Wegener's granulomatosis.

Authors:  Daniel Levine; Jonathan Akikusa; David Manson; Earl Silverman; Rayfel Schneider
Journal:  Pediatr Radiol       Date:  2006-10-28

8.  Cardiac involvement in Wegener's granulomatosis.

Authors:  N E Goodfield; S Bhandari; W D Plant; A Morley-Davies; G R Sutherland
Journal:  Br Heart J       Date:  1995-02

9.  Wegener's granulomatosis in childhood.

Authors:  K McHugh; D Manson; B A Eberhard; A Shore; R M Laxer
Journal:  Pediatr Radiol       Date:  1991

10.  A patient presenting with bilateral lung lesions, pleural effusion, and proteinuria.

Authors:  Katerina D Samara; Giorgos Papadogiannis; Andrew G Nicholson; Eleutherios Magkanas; Konstantinos Stylianou; Nikolaos Siafakas; Katerina M Antoniou
Journal:  Case Rep Med       Date:  2013-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.